EGFR and non-small cell lung carcinoma: In conclusion, the concurrent or sequential use of radiotherapy, chemotherapy and EGFR-TKI might have a better prospect in EGFR-mutated NSCLC patients with brain metastasis and/or leptomeningeal metastasis.